The specific maternal-neonatal immunity against respiratory syncytial virus after the COVID-19 pandemic: an observational study

Children in the first months of life are at highest risk for Respiratory Syncytial Virus (RSV) bronchiolitis. Maternal specific anti-RSV IgG antibodies play a key role in preventing infection in early life. The COVID-19 pandemic changed the seasonality of RSV epidemics. We hypothesized that COVID-19...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Maria Giulia Conti, Leonardo Sorrentino, Laura Petrarca, Enrica Mancino, Greta Di Mattia, Luigi Matera, Domenico La Regina, Matteo Fracella, Francesca Pulcinelli, Enea Bonci, Roberto Brunelli, Ilenia Mappa, Alessandra Pierangeli, Guido Antonelli, Gianluca Terrin, Raffaella Nenna, Fabio Midulla
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Taylor & Francis Group 2026-12-01
Rangatū:	The Journal of Maternal-Fetal & Neonatal Medicine
Ngā marau:	RSV COVID-19 bronchiolitis newborns pregnant women
Urunga tuihono:	https://www.tandfonline.com/doi/10.1080/14767058.2025.2603043
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!